Alogliptin

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) JHC049LO86. European Medicines Agency schedules Alogliptin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32564. Alogliptin generally arises in the molecular formula C18H21N5O2. The term ALOGLIPTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21, no. 3, 2007, list 58.) Most nations, for tariff and trade purposes, schedule alogliptin under HS 29335990 and SITC 51576. As of Q4 2014, ALOGLIPTIN remains US FDA's Preferred Term for this commodity. Alogliptin bears US NLM identifiers UMLS ID C1958126 and NCI Concept Code C76906. SMILES: CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.